Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0000905148-25-002980

Chief Accounting Officer sold 228 shares at $0.42 ($95)

  • Chief Accounting Officer acquired 602 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vazquez Chris · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-12 Exercise or conversion : show line 1 in the form +602 18,603 D
2025-08-13 Sale : show line 2 in the form −228 $0.42 $95 18,375 D
Open-market sales · 228 sh · avg $0.42 · $95

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-12 Exercise or conversion : show line 3 in the form Restricted Stock Units −602 1,203 D
Loading xslF345X05/form4.xml…